Mingbo Liu

机构：Weifang Medical University, Harbin Medical University, Chinese PLA General Hospital, National Clinical Research Center for Digestive Diseases, Second Affiliated Hospital of Guangzhou Medical University, Third Affiliated Hospital of Harbin Medical University, Chongqing Maternal and Child Health Hospital, Hainan General Hospital, Hainan 301 Hospital, Henan Provincial People's Hospital, Children's Hospital of Chongqing Medical University, Southern Medical University, Chongqing Medical University, Guangzhou Medical University · ORCID：0000-0002-0540-2573

发表论文 103 篇 · 总被引 1335 次 · h-index 21

代表论文

• Summary of the 2022 Report on Cardiovascular Health and Diseases in China (2023 · Chinese Medical Journal · 被引 155)
• Multicentre, cross-sectional surveillance of Helicobacter pylori prevalence and antibiotic resistance to clarithromycin and levofloxacin in urban China using the string test coupled with quantitative PCR (2024 · The Lancet Microbe · 被引 52)
• m6A/HOXA10-AS/ITGA6 axis aggravates oxidative resistance and malignant progression of laryngeal squamous cell carcinoma through regulating Notch and Keap1/Nrf2 pathways (2024 · Cancer Letters · 被引 29)
• 2024 annual report on cardiovascular health and diseases in China: Data and trend (2025 · Chinese Medical Journal · 被引 26)
• TME-Activated MnO2/Pt Nanoplatform of Hydroxyl Radical and Oxygen Generation to Synergistically Promote Radiotherapy and MR Imaging of Glioblastoma (2024 · International Journal of Nanomedicine · 被引 17)
• Rapid increasing burden of diabetes and cardiovascular disease caused by high body mass index in 1.25 million Chinese adults, 2005–2018 (2023 · Med · 被引 11)